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Introduction
Tissue factor (TF), plays a key role in pathophysiology
of disseminated intravascular coagulation (DIC) and
multiple organ dysfunction syndrome. Tissue factor
pathway inhibitor (TFPI) regulates tissue factor activity.
Several studies in septic patients have shown that TF
production exceeds TFPI production,promoting a pro-
thrombotic state.
Objective
The aim of our study was to record coagulation disor-
ders, during the course of different stages of sepsis. We
also measured TF and TFPI levels, while we investigated
the possible correlation of these parameters with morbid-
ity and mortality.
Methods
This prospective observational study was conducted in a
19-bed polyvalent adult intensive care unit of the “Atti-
kon” University Hospital, between November 2012 and
June 2013.TF and TFPA levels were recorded on day of
study entry (protocol day 0) and further followed once a
week (days 7 and 14 or until they were discharged from
ICU or until death). Tissue factor activity (TFa) was mea-
sured by homemade test of Stago Diagnostica. TFPI was
measured by immunoenzyme assay ELISA standard
phase. Disease severity at study entry according to Acute
Physiology and Chronic Health Evaluation (APACHE II)
score, the degree of organ dysfunction quantified by the
Sequential Organ Failure Assessment (SOFA) score, the
presence of DIC, as expressed by DIC score, the sepsis
stage, and the respective laboratory data, were recorded
on each protocol day.
Results
Twenty nine (19) mechanically ventilated septic patients
were enrolled in the study. Among them, 12 patients sur-
vived (63%) during ICU staying. Survivors were signifi-
cantly younger than non-survivors (p = 0.03), with higher
disease severity as expressed by APACHE II (p = 0.008).
DIC score was significantly higher in non survivors (p =
0.01). Mortality was higher in patients with severe sepsis/
septic shock, as compared to patients with sepsis/SIRS
(p = 0.02). The latter group of patients showed signifi-
cantly lower DIC and SOFA scores. TFa has higher in non
survivors (p = 0.007). It also showed a trend to be higher
in patients with severe sepsis/septic shock, while the differ-
ence became significant on study day 14. TFPI tended to
be higher in the same group of patients. A significant cor-
relation was observed between TFPI and INR values on
study day 0 (Pearson coefficient = 0.9, p = 0.001), between
DIC score and APACHE II, and DIC score with SOFA.
Conclusions
The activation of coagulation in sepsis, as expressed by
DIC score, is significantly correlated to organ dysfunction
and subsequent mortality. The observed imbalance
between TF and TFPI might have a prognostic value.
Larger studies are needed, in order to confirm these
results, and lead to possible therapeutic considerations
targeting to sepsis associated DIC and organ dysfunction.
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